【结 构 式】 |
【药物名称】 【化学名称】2-(2-Ethyl-1H-imidazol-1-yl)-N-[4-[N-methyl-N-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexyloxy]phenyl]carbamoyl]phenyl]benzamide 【CA登记号】 【 分 子 式 】C38H46N6O4 【 分 子 量 】650.82812 |
【开发单位】Yamanouchi (Originator) 【药理作用】CARDIOVASCULAR DRUGS, Diuretics, Heart Failure Therapy, Hypertension, Treatment of, RENAL-UROLOGIC DRUGS, Vasopressin V1a Antagonists |
合成路线1
Acylation of the anilino ester (I) with 4-nitrobenzoyl chloride (II) affords amide (III). After reduction of the 4-nitrobenzamide (III) by catalytic hydrogenation, the resultant amine (IV) is condensed with (2-ethyl-1-imidazolyl)benzoyl chloride (V) to furnish diamide (VI). Subsequent ester group saponification in (VI) gives acid (VII). This is finally coupled with N-methylpiperazine (VIII) in the presence of EDC and HOBt to produce the title compound.
【1】 Kakefuda, A.; Kusayama, T.; Tahara, A.; Tsukamoto, S.-I.; Tsukada, J.; N-Methylbenzanilide derivatives as a novel class of selective V1A receptor antagonists. Bioorg Med Chem Lett 2002, 12, 2, 229. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 57789 | ethyl 6-[5-methyl-2-(methylamino)phenoxy]hexanoate | C16H25NO3 | 详情 | 详情 | |
(II) | 18941 | p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride | 122-04-3 | C7H4ClNO3 | 详情 | 详情 |
(III) | 57790 | ethyl 6-{5-methyl-2-[methyl(4-nitrobenzoyl)amino]phenoxy}hexanoate | C23H28N2O6 | 详情 | 详情 | |
(IV) | 57791 | ethyl 6-{2-[(4-aminobenzoyl)(methyl)amino]-5-methylphenoxy}hexanoate | C23H30N2O4 | 详情 | 详情 | |
(V) | 57792 | 2-(2-ethyl-1H-imidazol-1-yl)benzoyl chloride | C12H11ClN2O | 详情 | 详情 | |
(VI) | 57793 | ethyl 6-{2-[(4-{[2-(2-ethyl-1H-imidazol-1-yl)benzoyl]amino}benzoyl)(methyl)amino]-5-methylphenoxy}hexanoate | C35H40N4O5 | 详情 | 详情 | |
(VII) | 57794 | 6-{2-[(4-{[2-(2-ethyl-1H-imidazol-1-yl)benzoyl]amino}benzoyl)(methyl)amino]-5-methylphenoxy}hexanoic acid | C33H36N4O5 | 详情 | 详情 | |
(VIII) | 10061 | 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine | 109-01-3 | C5H12N2 | 详情 | 详情 |